Placental transfer of IgG subclasses in a Japanese population.

Pediatrics international : official journal of the Japan Pediatric Society (2000-09-15)
S Hashira, S Okitsu-Negishi, K Yoshino
ABSTRACT

Maternal immunoglobulin G (IgG), transferred across the placenta to the fetus during intrauterine life, is an important component of the neonatal immunological defence mechanisms against infection. There is controversy with respect to differences in placental transfer of the different IgG subclasses, and no definite data are available on a Japanese population. Therefore, we investigated placental transfer of IgG subclasses in a Japanese population. A total of 228 matched pairs of cord and maternal serum samples (20-42 weeks gestation) were assayed for each IgG subclass by an enzyme-linked immunosorbent assay. The mean values and hierarchy of cord/maternal concentration ratios of IgG subclasses at 40 weeks gestation were as follows: IgG1(1.47) > IgG3(1.17) = IgG4(1.15) > IgG2(0.80). The cord/maternal concentration ratios of all IgG subclasses were positively correlated to gestational age. The mean ratios for IgG1 and IgG4 nearly reached a plateau at 39 and 37 weeks gestation, respectively, while those for IgG2 and IgG3 increased until 41 weeks gestation. The ratios of all IgG subclasses for full-term deliveries were reciprocally correlated to the respective maternal IgG subclass serum levels. The results suggest that although all four IgG subclasses are actively transferred across the placenta, the efficiency of their transfer ranks in the order IgG1 > IgG3 = IgG4 > IgG2. The different results as to placental transfer of IgG subclasses in the literature might be due, at least in part, to different maternal IgG subclass serum levels in the populations studied.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
IgG from human serum, reagent grade, ≥95% (SDS-PAGE), essentially salt-free, lyophilized powder
Sigma-Aldrich
Anti-Human IgG (Fc specific) antibody produced in goat, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
IgG from rabbit serum, reagent grade, ≥95% (SDS-PAGE), essentially salt-free, lyophilized powder
Sigma-Aldrich
Anti-Mouse IgG (whole molecule)–Peroxidase antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
IgG from mouse serum, reagent grade, ≥95% (SDS-PAGE), lyophilized powder
Sigma-Aldrich
IgG from bovine serum, reagent grade, ≥95% (SDS-PAGE), essentially salt-free, lyophilized powder
Sigma-Aldrich
IgG1, Kappa from human myeloma plasma, purified immunoglobulin, >95% (SDS-PAGE)
Sigma-Aldrich
IgG from human serum, reagent grade, ≥95% (HPLC), buffered aqueous solution
Sigma-Aldrich
Immunoglobulin G from human serum, ≥95% (GE)
Sigma-Aldrich
Anti-Mouse IgG (whole molecule) antibody produced in goat, affinity isolated antibody, lyophilized powder
Sigma-Aldrich
IgG from goat serum, reagent grade, ≥95% (SDS-PAGE), essentially salt-free, lyophilized powder
Sigma-Aldrich
Anti-Mouse IgG (whole molecule)–FITC antibody produced in goat, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-Mouse IgG (whole molecule) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
IgG from rat serum, reagent grade, ≥95% (SDS-PAGE), essentially salt-free, lyophilized powder
Sigma-Aldrich
IgG from mouse serum, technical grade, ≥80% (SDS-PAGE), buffered aqueous solution
Sigma-Aldrich
Anti-Human IgG (Fc specific)−FITC antibody produced in goat, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
IgG2, Kappa from human myeloma plasma, purified immunoglobulin, >95% (SDS-PAGE)
Sigma-Aldrich
IgG from goat serum, technical grade, ≥80% (SDS-PAGE), buffered aqueous solution
Sigma-Aldrich
Anti-Rabbit IgG (whole molecule) antibody produced in goat, affinity isolated antibody, lyophilized powder
Sigma-Aldrich
IgG from rabbit serum, technical grade, ≥80% (SDS-PAGE), buffered aqueous solution
Sigma-Aldrich
IgG from human serum, technical grade, ≥80% (SDS-PAGE), buffered aqueous solution
Sigma-Aldrich
IgG1, Lambda from human myeloma plasma, purified immunoglobulin, >95% (SDS-PAGE)
Sigma-Aldrich
Anti-Rabbit IgG (whole molecule)–FITC antibody produced in goat, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-Dog IgG (whole molecule)–FITC antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
IgG3, Kappa from human myeloma plasma, purified immunoglobulin, >90% (microfluidic capillary gel electrophoresis)
Sigma-Aldrich
Anti-Human IgG (Fc specific)−Biotin antibody, Mouse monoclonal, clone HP-6017, purified from hybridoma cell culture
Sigma-Aldrich
Anti-Mouse IgG (whole molecule)−FITC antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
IgG from sheep serum, reagent grade, ≥95% (SDS-PAGE), essentially salt-free, lyophilized powder
Sigma-Aldrich
Anti-Human IgG (Fab specific), F(ab′)2 fragment antibody produced in goat, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
IgG1, Kappa from murine myeloma, clone MOPC 21, purified immunoglobulin, buffered aqueous solution

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.